Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $29,683 | 8 | 83.1% |
| Travel and Lodging | $2,703 | 12 | 7.6% |
| Food and Beverage | $2,220 | 40 | 6.2% |
| Unspecified | $1,080 | 2 | 3.0% |
| Education | $12.23 | 2 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $21,312 | 38 | $0 (2021) |
| Bard Peripheral Vascular, Inc. | $7,844 | 7 | $0 (2018) |
| Merit Medical Systems Inc | $3,619 | 5 | $0 (2018) |
| Covidien LP | $1,520 | 2 | $0 (2020) |
| Medtronic, Inc. | $700.00 | 1 | $0 (2018) |
| AKEBIA THERAPEUTICS INC | $219.86 | 2 | $0 (2024) |
| BAXTER HEALTHCARE | $124.71 | 1 | $0 (2018) |
| Fresenius USA Marketing, Inc. | $96.99 | 3 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $94.15 | 1 | $0 (2024) |
| Amgen Inc. | $74.67 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $314.01 | 3 | AKEBIA THERAPEUTICS INC ($219.86) |
| 2022 | $65.05 | 2 | Fresenius USA Marketing, Inc. ($65.05) |
| 2021 | $284.92 | 4 | AstraZeneca Pharmaceuticals LP ($222.08) |
| 2020 | $4,724 | 10 | AstraZeneca Pharmaceuticals LP ($3,584) |
| 2019 | $17,535 | 24 | AstraZeneca Pharmaceuticals LP ($17,145) |
| 2018 | $5,082 | 15 | Merit Medical Systems Inc ($3,619) |
| 2017 | $7,693 | 6 | Bard Peripheral Vascular, Inc. ($7,619) |
All Payment Transactions
64 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Nephrology | ||||||
| 08/14/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $94.86 | General |
| Category: Nephrology | ||||||
| 02/14/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $94.15 | General |
| 06/22/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug), OPTIFLUX | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: Phosphate binder for ESRD | ||||||
| 03/01/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $38.61 | General |
| Category: Phosphate binder for ESRD | ||||||
| 08/19/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $102.55 | General |
| 07/07/2021 | Abbott Laboratories | HeartMate 3 Left Ventricular Assist Device (Device) | Food and Beverage | In-kind items and services | $62.84 | General |
| Category: Heart Failure | ||||||
| 06/15/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $102.24 | General |
| 04/21/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/13/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Consulting Fee | Cash or cash equivalent | $3,334.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/19/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/19/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Education | In-kind items and services | $5.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/30/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $103.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/16/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/29/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $7.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/10/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/18/2020 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $26.50 | General |
| 02/09/2020 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $42.16 | General |
| 01/23/2020 | Covidien LP | Chameleon (Device) | Consulting Fee | Cash or cash equivalent | $1,140.00 | General |
| Category: Percutaneous Transluminal Angioplasty (PTA) Balloons | ||||||
| 11/08/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/05/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $103.89 | General |
| 06/09/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Consulting Fee | Cash or cash equivalent | $5,850.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/17/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Travel and Lodging | In-kind items and services | $433.51 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/17/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Travel and Lodging | In-kind items and services | $433.51 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/17/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Travel and Lodging | In-kind items and services | $237.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 69 | 154 | $38,470 | $12,391 |
| 2021 | 2 | 123 | 244 | $56,440 | $20,921 |
| 2020 | 2 | 82 | 134 | $30,988 | $12,302 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 39 | 112 | $23,632 | $8,460 | 35.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 22 | $7,238 | $2,822 | 39.0% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 12 | 20 | $7,600 | $1,108 | 14.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 82 | 202 | $42,622 | $14,956 | 35.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 41 | 42 | $13,818 | $5,964 | 43.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 59 | 111 | $23,421 | $8,899 | 38.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 23 | 23 | $7,567 | $3,403 | 45.0% |
About Dr. Stephen Ash, MD
Dr. Stephen Ash, MD is a Nephrology healthcare provider based in Lafayette, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417926940.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Ash, MD has received a total of $35,698 in payments from pharmaceutical and medical device companies, with $314.01 received in 2024. These payments were reported across 64 transactions from 12 companies. The most common payment nature is "Consulting Fee" ($29,683).
As a Medicare-enrolled provider, Ash has provided services to 274 Medicare beneficiaries, totaling 532 services with total Medicare billing of $45,613. Data is available for 3 years (2020–2022), covering 7 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Lafayette, IN
- Active Since 03/16/2006
- Last Updated 01/28/2021
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1417926940
Products in Payments
- LOKELMA (Drug) $20,470
- Chameleon (Device) $1,140
- Auryxia (Drug) $219.86
- Renal - Sharesource (Device) $124.71
- BPV-Glidepath Catheter (Device) $95.80
- Parsabiv (Biological) $74.67
- Velphoro (Drug) $65.05
- HeartMate 3 Left Ventricular Assist Device (Device) $62.84
- Not Product Related (Medical Supply) $31.94
- BRILINTA (Drug) $20.22
- FARXIGA (Drug) $5.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Lafayette
Anthony Blalock, M.d, M.D
Nephrology — Payments: $340,087
Dr. Ziad Ashkar, M.d, M.D
Nephrology — Payments: $17,946
Dr. Juan Zeik, M.d, M.D
Nephrology — Payments: $6,384
Akshey Gupta, M.d, M.D
Nephrology — Payments: $5,800
Dr. Maximo Lamarche, M.d, M.D
Nephrology — Payments: $5,215
Shamir Hasan, Do, DO
Nephrology — Payments: $2,674